You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Ajanta Pharma Ltd"

Ajanta Pharma Ltd Investor Presentation Q3 FY 2017

  • 24/01/2017
  • |
  • bse

Ajanta Pharma Ltd Announces Q3 results (Standalone & Consolidated) Limited Review Report (Standalone & Consolidated) &

  • 24/01/2017
  • |
  • bse

Ajanta Pharma Ltd No import alert on us by US FDA

  • 24/01/2017
  • |
  • bse

Ajanta Pharma Ltd Clarifies on News item

  • 24/01/2017
  • |
  • bse

Ajanta Pharma Ltd Clarification sought from Ajanta Pharma Ltd

  • 24/01/2017
  • |
  • bse

Ajanta Pharma Ltd Q3 results on Jan 24 2017

  • 13/01/2017
  • |
  • bse

Ajanta Pharma Ltd Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended D

  • 10/01/2017
  • |
  • bse

Ajanta Pharma Ltd Ajanta Pharma Announces US FDA Approval for Duloxetine Hydrochloride Delayed Release Capsules

  • 09/01/2017
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 23/12/2016
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 20/12/2016
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 19/12/2016
  • |
  • bse

Ajanta Pharma Ltd Updates

  • 25/11/2016
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 21/11/2016
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

  • 21/11/2016
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 21/11/2016
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011

  • 21/11/2016
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulation

  • 10/11/2016
  • |
  • bse

Ajanta Pharma Ltd Ajanta Pharma Announces Approval & Launch of Amlodipine + Olmesartan Medoxomil Tablets in US Market

  • 02/11/2016
  • |
  • bse

Ajanta Pharma Ltd Dividend Payment Date

  • 27/10/2016
  • |
  • bse

Ajanta Pharma Ltd Investor Presentation

  • 26/10/2016
  • |
  • bse